Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.
Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.
复制标题
DOI:
10.4049/jimmunol.1501821
复制
发表时间:
2016-05-15
期刊:
影响因子:
--
通讯作者:
Hildebrand WH
中科院分区:
文献类型:
--
作者:
Kaabinejadian S;McMurtrey CP;Kim S;Jain R;Bardet W;Schafer FB;Davenport JL;Martin AD;Diamond MS;Weidanz JA;Hansen TH;Hildebrand WH
Class I Human Leukocyte Antigens (HLA) mark infected cells for immune targeting by presenting pathogen encoded peptides on the cell surface. Characterization of viral peptides unique to infected cells is important for understanding CD8+ T cell responses and for the development of T cell-based immunotherapies. Having previously reported a series of West Nile virus (WNV) epitopes that are naturally presented by HLA-A*02:01, here we generated T cell receptor mimic monoclonal antibodies (TCRm mAbs) to three of these peptide/HLA complexes - the immunodominant SVG9 (E protein), the subdominant SLF9 (NS4B protein), and the immunorecessive YTM9 (NS3 protein) - and used these TCRm mAbs to stain WNV infected cell lines and primary antigen presenting cells. TCRm staining of WNV infected cells demonstrated that the immunorecessive YTM9 appeared several hours earlier and at 5 to 10 fold greater density than the more immunogenic SLF9 and SVG9 ligands. Moreover, staining following inhibition of the transporter associated with antigen processing (TAP) demonstrated that all three viral ligands were presented in a TAP-dependent manner despite originating from different cellular compartments. This study represents the first use of TCRm mAbs to define the kinetics and magnitude of HLA presentation for a series of epitopes encoded by one virus, and the results depict a pattern whereby individual epitopes differ considerably in abundance and availability. The observation that immunodominant ligands can be found at lower levels and at later time points post-infection suggests that a reevaluation of the factors that combine to shape T cell reactivity may be warranted.